Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
European Journal of Heart Failure
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration With the International Cardio-Oncology Society
Eur. J. Heart Fail 2020 May 28;[EPub Ahead of Print], AR Lyon, S Dent, S Stanway, H Earl, C Brezden-Masley, A Cohen-Solal, CG Tocchetti, JJ Moslehi, JD Groarke, J Bergler-Klein, V Khoo, LL Tan, MS Anker, S von Haehling, C Maack, R Pudil, A Barac, P Thavendiranathan, B Ky, TG Neilan, Y Belenkov, SD Rosen, Z Iakobishvili, AL Sverdlov, LA Hajjar, AVS Macedo, C Manisty, F Ciardiello, D Farmakis, RA de Boer, H Skouri, TM Suter, D Cardinale, RM Witteles, MG Fradley, J Herrmann, RF Cornell, A Wechelaker, MJ Mauro, D Milojkovic, H de Lavallade, F Ruschitzka, AJS Coats, PM Seferovic, O Chioncel, T Thum, J Bauersachs, MS Andres, DJ Wright, T López-Fernández, C Plummer, D LenihanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.